Comparison of the Panax Ginseng + Associations to Ginkgo Biloba in the Treatment of Cognitive Function Disorders
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of two different drugs in
the treatment of patients diagnosed with memory difficulties and a decline in cognitive
function.
This is a parallel distribution: a group of patients will be treated with a combination Panax
Ginseng + Ginkgo Biloba + multivitamin + Polyminerals (EMS), and another group with Ginkgo
Biloba (Tebonin ®).